AN2 Therapeutics (ANTX) Earnings Date & Reports

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

Industry: #Managed Health Care

Get AI intraday signals

A.I. Advisor

published Earnings

ANTX is expected to report earnings to rise 33.33% to -23 cents per share on November 05

AN2 Therapeutics ANTX Stock Earnings Reports

Q3'26

Est.

$-0.24

Q2'26

Beat

by $0.05

Q1'26

Missed

by $0.06

Q4'25

Missed

by $0.07

Q3'25

Est.

$-0.31

The last earnings report on August 11 showed earnings per share of -18 cents, beating the estimate of -23 cents. With 49.97K shares outstanding, the current market capitalization sits at 225.66M.

View a ticker or compare two or three

ANTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days